Emergence of Streptococcus pneumoniae Serotype 12F after Sequential Introduction of 7- and 13-Valent Vaccines, Israel - Volume 24, Number 3—March 2018 - Emerging Infectious Disease journal - CDC

Emergence of Streptococcus pneumoniae Serotype 12F after Sequential Introduction of 7- and 13-Valent Vaccines, Israel - Volume 24, Number 3—March 2018 - Emerging Infectious Disease journal - CDC

Volume 24, Number 3—March 2018

Research

Emergence of Streptococcus pneumoniae Serotype 12F after Sequential Introduction of 7- and 13-Valent Vaccines, Israel

Assaf Rokney , Shalom Ben-Shimol, Zinaida Korenman, Nurith Porat, Zeev Gorodnitzky, Noga Givon-Lavi, Merav Ron, Vered Agmon, Ron Dagan, and Lea Valinsky

Author affiliations: Ministry of Health, Jerusalem, Israel (A. Rokney, Z. Korenman, Z. Gorodnitzky, M. Ron, V. Agmon, L. Valinsky); Soroka University Medical Center, Beer Sheva, Israel (S. Ben-Shimol, N. Porat, N. Givon-Lavi); Ben-Gurion University of the Negev, Beer Sheva (S. Ben-Shimol, N. Porat, N. Givon-Lavi, R. Dagan)

Main Article

Figure 6

Figure 6. Multilocus sequence typing comparison of Streptococcus pneumoniae serotype 12F serotype isolates from Israel and globally.

Main Article